Walgreens Boots Alliance Inc. Faces a Potential Three-Way Split

In a move that could reshape the landscape of the pharmacy industry, Walgreens Boots Alliance Inc. is reportedly in talks for a buyout by the private equity firm Sycamore Partners. This deal could lead to the division of the company into three distinct units, according to a report by the Financial Times.

Breaking Down the Potential Split

The proposed split would see the separation of the United States retailer Walgreens, the United Kingdom chemist and retail group Boots, and the specialty pharma unit Shields Health Solutions. Stefano Pessina, Walgreens' executive chairman, is expected to retain a significant shareholding in the company post-split.

Financing Not a Concern

Despite the complexity of the deal, financing for the potential acquisition is not anticipated to pose a significant obstacle, signaling strong confidence from Sycamore Partners in the value and future of Walgreens' diversified business units.